Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Healthtrust
Chubb
Express Scripts
AstraZeneca
UBS
Colorcon
Harvard Business School
Argus Health

Generated: June 19, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin degludec

« Back to Dashboard

insulin degludec

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novo Nordisk Inc TRESIBA insulin degludec SOLUTION;SUBCUTANEOUS 203314 NDA Novo Nordisk N 0169-2550-13
Novo Nordisk Inc TRESIBA insulin degludec SOLUTION;SUBCUTANEOUS 203314 NDA Novo Nordisk N 0169-2550-97
Novo Nordisk Inc TRESIBA insulin degludec SOLUTION;SUBCUTANEOUS 203314 NDA Novo Nordisk N 0169-2660-15
Novo Nordisk Inc TRESIBA insulin degludec SOLUTION;SUBCUTANEOUS 203314 NDA Novo Nordisk N 0169-2660-97
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKinsey
Federal Trade Commission
US Army
Johnson and Johnson
Cerilliant
Fish and Richardson
Chinese Patent Office
Harvard Business School